Between 40 and 50 percent of Americans who live to age 65 will have either basal cell carcinoma or squamous cell carcinoma at least once.
The annual cost of treating skin cancers in the U.S. is estimated at $8.1 billion: about $4.8 billion for nonmelanoma skin cancers and $3.3 billion for melanoma.
An estimated 9,730 people will die of melanoma in 2017.
The estimated 5-year survival rate for patients whose melanoma is detected early is about 98 percent in the U.S. The survival rate falls to 62 percent when the disease reaches the lymph nodes, and 18 percent when the disease metastasizes to distant organs
Our project plans to train and classify skin cancer types so that user can try to detect cancer in the real time. When detected with high confidence score, user will be given suggestion to see dermatologist for effective treatments.